Home

Prevention

Read time: 3 min

Congress highlights

Understanding the anhedonia across and beyond the schizophrenia

Anhedonia refers to the reduced ability to experience pleasure and happiness.1 It is one of...

Read time: 4 min

Congress highlights

Salivary calcitonin gene-related peptide as a potential biomarker for migraine

Levels of calcitonin gene-related peptide (CGRP) are higher in patients with migraine in the...

Bipolar, Schizophrenia

Read time: 5 min

Congress highlights

Exploring the transmission of mental illness from parents to children

A family history of severe mental illness (SMI) is a known risk factor for the development of SMI...

Read time: 4 min

Congress highlights

Prevention: use every tool in the box

Finding the optimum combination of medical interventions and lifestyle factors can decrease...

Read time: 5 min

Congress highlights

Exploring the relationship between cannabis use and psychosis

Epidemiological evidence demonstrates an association between the use of cannabis and increased risk...

Bipolar, Schizophrenia

Read time: 5 min

Congress highlights

Poor Heart Health Outcomes in Patients with Mental Illness

Patients living with serious mental illnesses (SMI) have high rates of cardiovascular morbidity and...

Medical education resource center

Lundbeck Institute Campus

The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Israel
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in the Israel click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country